I 
112TH CONGRESS 
2D SESSION 
H. R. 5711 
To amend the Public Health Service Act to provide grants for treatment 
of heroin, cocaine, methamphetamine, 3,4-methylenedioxymethamphet-
amine (ecstasy), and phencyclidine (PCP) abuse, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
MAY 10, 2012 
Mr. CARNAHAN (for himself, Ms. BASS of California, Mr. BLUMENAUER, Mr. 
CARSON of Indiana, Mr. COHEN, Mr. CONYERS, Mr. DAVIS of Illinois, 
Mr. FILNER, Mr. GRIJALVA, Ms. HAHN, Mr. HASTINGS of Florida, Mr. 
JACKSON of Illinois, Ms. JACKSON LEE of Texas, Ms. EDDIE BERNICE 
JOHNSON of Texas, Mr. KUCINICH, Ms. LEE of California, Ms. MCCOL-
LUM, Ms. NORTON, Mr. RANGEL, Mr. REYES, Ms. RICHARDSON, Mr. 
ROSS of Arkansas, Mr. RUSH, Mr. RYAN of Ohio, Mr. SABLAN, Ms. SE-
WELL, Mr. TONKO, Mr. TOWNS, Ms. WATERS, and Ms. WOOLSEY) intro-
duced the following bill; which was referred to the Committee on Energy 
and Commerce, and in addition to the Committee on the Budget, for a 
period to be subsequently determined by the Speaker, in each case for 
consideration of such provisions as fall within the jurisdiction of the com-
mittee concerned 
A BILL 
To amend the Public Health Service Act to provide grants 
for treatment of heroin, cocaine, methamphetamine, 3,4- 
methylenedioxymethamphetamine (ecstasy), and phency-
clidine (PCP) abuse, and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
VerDate Mar 15 2010 
22:54 May 14, 2012
Jkt 019200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H5711.IH
H5711
srobinson on DSK4SPTVN1PROD with BILLS
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Access to Substance 
Abuse Treatment Act of 2012’’. 
SEC. 2. PURPOSE. 
It is the purpose of this Act to— 
(1) reduce crime and improve public safety by 
making treatment for heroin, cocaine, methamphet-
amine, 
3,4-methylenedioxymethamphetamine 
(ec-
stasy), and phencyclidine (PCP) abuse available to 
every American who needs it; 
(2) keep families together by encouraging alter-
natives to incarceration for nonviolent drug law of-
fenses; 
(3) help identify root causes and most effective 
treatment methods for heroin, cocaine, methamphet-
amine, 3,4-methylenedioxymethamphetamine, and 
phencyclidine abuse; and 
(4) expand research into cutting-edge treatment 
methods for stimulant abuse. 
SEC. 
3. 
HEROIN, 
COCAINE, 
METHAMPHETAMINE, 
3,4- 
METHYLENEDIOXYMETHAMPHETAMINE 
(EC-
STASY), AND PHENCYCLIDINE (PCP) TREAT-
MENT AND WRAP-AROUND PROGRAMS. 
Subpart 1 of part B of title V of the Public Health 
Service Act is amended— 
VerDate Mar 15 2010 
22:54 May 14, 2012
Jkt 019200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H5711.IH
H5711
srobinson on DSK4SPTVN1PROD with BILLS
(1) redesignating the second section 514 (relat-
ing to methamphetamine and amphetamine treat-
ment) as section 514B; and 
(2) adding at the end the following new sec-
tions: 
‘‘SEC. 514C. INITIATIVE TO INCREASE HEROIN, COCAINE, 
METHAMPHETAMINE, 
ECSTASY, 
AND 
PCP 
TREATMENT CAPACITY. 
‘‘(a) IN GENERAL.—The Secretary may make grants 
to State, local, and tribal governments for the purpose of 
increasing the availability of treatment for heroin, cocaine, 
methamphetamine, 3,4-methylenedioxymethamphetamine 
(ecstasy), and phencyclidine (PCP) abuse. 
‘‘(b) REQUIREMENTS.— 
‘‘(1) IN GENERAL.—To seek a grant under sub-
section (a), a State, local, or tribal government shall 
submit an application to the Secretary at such time, 
in such manner, and containing such information 
and assurances as the Secretary may require. 
‘‘(2) USE OF GRANT FUNDS.—The grants made 
under subsection (a) may only be used to— 
‘‘(A) build treatment centers; 
‘‘(B) expand existing treatment centers; 
‘‘(C) hire treatment professionals; 
VerDate Mar 15 2010 
22:54 May 14, 2012
Jkt 019200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H5711.IH
H5711
srobinson on DSK4SPTVN1PROD with BILLS
‘‘(D) provide training and education to 
substance abuse professionals, medical profes-
sionals, and educators related to the treatment 
of heroin, cocaine, methamphetamine, 3,4- 
methylenedioxymethamphetamine, and phency-
clidine abuse; and 
‘‘(E) engage in other activities that the 
Secretary has determined are relevant to the 
purpose of the grants under subsection (a). 
‘‘(c) AUTHORIZATION OF APPROPRIATIONS.—There 
are authorized to be appropriated such sums as may be 
necessary to carry out this section for fiscal years 2013 
through 2017. 
‘‘SEC. 514D. HEROIN, COCAINE, METHAMPHETAMINE, EC-
STASY, AND PCP ABUSE TREATMENT VOUCH-
ERS FOR UNDERSERVED POPULATIONS. 
‘‘(a) IN GENERAL.—The Secretary may make grants 
to State, local, and tribal governments and nonprofit enti-
ties to provide vouchers to individuals in underserved pop-
ulations for authorized services related to the treatment 
of such individuals for heroin, cocaine, methamphetamine, 
3,4-methylenedioxymethamphetamine (ecstasy), and phen-
cyclidine (PCP) abuse. 
‘‘(b) REQUIREMENTS.— 
VerDate Mar 15 2010 
22:54 May 14, 2012
Jkt 019200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H5711.IH
H5711
srobinson on DSK4SPTVN1PROD with BILLS
‘‘(1) APPLICATION.—To seek a grant under 
subsection (a), a State, local, or tribal government 
or a nonprofit entity shall submit an application to 
the Secretary at such time, in such manner, and 
containing such information and assurances as the 
Secretary may require, including a description of the 
method that such State, government, or entity will 
use— 
‘‘(A) to identify individuals who would ben-
efit from treatment for heroin, cocaine, meth-
amphetamine, 3,4-methylenedioxymethamphet-
amine, or phencyclidine abuse; 
‘‘(B) to identify if such individuals are in 
underserved populations; and 
‘‘(C) to provide vouchers to such individ-
uals in such populations. 
‘‘(2) PRESERVATION OF CHOICE.—A recipient 
of a grant under this section may not restrict the 
ability of an individual receiving a voucher under 
this section to use the voucher to pay for authorized 
services furnished by any provider of authorized 
services, so long as the provider of such services 
meets all applicable State licensure or certification 
requirements regarding the provision of such serv-
ices. 
VerDate Mar 15 2010 
22:54 May 14, 2012
Jkt 019200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H5711.IH
H5711
srobinson on DSK4SPTVN1PROD with BILLS
‘‘(3) DURATION OF AWARD.—With respect to a 
grant under this section, the period during which 
payments under such grant are made to the grant 
recipient may not exceed five years. 
‘‘(4) MATCHING
FUNDS.—The Secretary may 
require that recipients of grants under this section 
provide non-Federal matching funds, as determined 
appropriate by the Secretary, to ensure the commit-
ment of the grant recipients to the provision of 
vouchers for treatment to individuals who use her-
oin, cocaine, methamphetamine, 3,4-methylenedioxy-
methamphetamine, or phencyclidine. Such non-Fed-
eral matching funds may be provided directly or 
through donations from public or private entities 
and may be in cash or in-kind, fairly evaluated, in-
cluding property, equipment, or services. 
‘‘(5) MAINTENANCE
OF
EFFORT.—The Sec-
retary may require that grant recipients under this 
section agree to maintain expenditures of non-Fed-
eral amounts for authorized services related to the 
treatment of heroin, cocaine, methamphetamine, 3,4- 
methylenedioxymethamphetamine, and phencyclidine 
abuse at a level that is not less than the level of 
such expenditures maintained by the recipient for 
VerDate Mar 15 2010 
22:54 May 14, 2012
Jkt 019200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H5711.IH
H5711
srobinson on DSK4SPTVN1PROD with BILLS
the fiscal year preceding the fiscal year for which 
the entity receives such a grant. 
‘‘(c) REPORT.— 
‘‘(1) IN GENERAL.—Not later than December 1, 
2013, and annually thereafter, the Secretary shall 
submit a report to the Congress on the grants under 
subsection (a). 
‘‘(2) CONTENTS OF REPORT.—The report under 
paragraph (1) shall contain an evaluation of the ef-
fectiveness of the grants made under subsection (a) 
in improving access to heroin, cocaine, methamphet-
amine, 3,4-methylenedioxymethamphetamine, and 
phencyclidine treatment for underserved populations. 
‘‘(d) DEFINITIONS.—For purposes of this section: 
‘‘(1) AUTHORIZED SERVICES.—The term ‘au-
thorized services’ means— 
‘‘(A) treatment for heroin, cocaine, meth-
amphetamine, 3,4-methylenedioxymethamphet-
amine, or phencyclidine abuse, including indi-
vidual, group, and family counseling regarding 
such abuse; 
‘‘(B) follow-up services to prevent an indi-
vidual from relapsing into such abuse; 
‘‘(C) wrap-around services, as such term is 
defined in section 514E(e)(4); and 
VerDate Mar 15 2010 
22:54 May 14, 2012
Jkt 019200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H5711.IH
H5711
srobinson on DSK4SPTVN1PROD with BILLS
‘‘(D) any additional services specified by 
the Secretary. 
‘‘(2) UNDERSERVED
POPULATION.—The term 
‘underserved population’ means a population of indi-
viduals who cannot access appropriate substance 
abuse treatment (including comprehensive substance 
abuse treatment) due to financial, geographical, lan-
guage, socioeconomic, or cultural barriers. 
‘‘(e) AUTHORIZATION OF APPROPRIATIONS.—There 
are authorized to be appropriated such sums as may be 
necessary to carry out this section for fiscal years 2013 
through 2017. 
‘‘SEC. 514E. COMPREHENSIVE WRAP-AROUND HEROIN, CO-
CAINE, METHAMPHETAMINE, 3,4-METHYLENE-
DIOXYMETHAMPHETAMINE (ECSTASY), AND 
PHENCYCLIDINE (PCP) TREATMENT SERV-
ICES. 
‘‘(a) IN GENERAL.—The Secretary may make grants 
to public, private, and nonprofit entities, Indian tribes, 
and tribal organizations to establish programs to provide 
for and coordinate the provision of wrap-around services 
to heroin, cocaine, methamphetamine, 3,4-methylenedioxy-
methamphetamine, or phencyclidine-affected individuals. 
‘‘(b) MINIMUM QUALIFICATIONS FOR RECEIPT OF 
AWARD.—To seek a grant under subsection (a), a public, 
VerDate Mar 15 2010 
22:54 May 14, 2012
Jkt 019200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6201
E:\BILLS\H5711.IH
H5711
srobinson on DSK4SPTVN1PROD with BILLS
private, or nonprofit entity, an Indian tribe, or a tribal 
organization shall submit an application to the Secretary 
at such time, in such manner, and containing such infor-
mation and assurances as the Secretary may require, in-
cluding assurances to the satisfaction of the Secretary 
that— 
‘‘(1) the applicant has the capacity to carry out 
a program described in subsection (a); 
‘‘(2) the applicant has entered into agreements 
with entities in the community involved, through 
which the applicant will provide wrap-around serv-
ices; and 
‘‘(3) the applicant, or any entity through which 
the applicant will provide such services, meets all ap-
plicable State licensure or certification requirements 
regarding the provision of such services. 
‘‘(c) PRIORITY FOR GRANT DISTRIBUTION.—In mak-
ing grants under this section, the Secretary shall give pri-
ority to applications for programs that serve communities 
with a high or increasing rate of heroin, cocaine, meth-
amphetamine, 3,4-methylenedioxymethamphetamine, or 
phencyclidine abuse or addiction, as specified by the Sec-
retary. 
‘‘(d) REPORTS.—For each year that a public, private, 
or nonprofit entity, Indian tribe, or tribal organization re-
VerDate Mar 15 2010 
22:54 May 14, 2012
Jkt 019200
PO 00000
Frm 00009
Fmt 6652
Sfmt 6201
E:\BILLS\H5711.IH
H5711
srobinson on DSK4SPTVN1PROD with BILLS
ceives a grant under subsection (a) for a program, such 
entity, tribe, or organization shall submit to the Secretary 
a report on the results and effectiveness of the program. 
‘‘(e) DEFINITIONS.—For purposes of this section: 
‘‘(1) HEROIN, COCAINE, METHAMPHETAMINE, 
3,4-METHYLENEDIOXYMETHAMPHETAMINE, 
OR 
PHENCYCLIDINE-AFFECTED INDIVIDUAL.—The term 
‘heroin, cocaine, methamphetamine, 3,4-methylene-
dioxymethamphetamine, or phencyclidine-affected in-
dividual’ means an individual who— 
‘‘(A)(i) resided in a residential inpatient 
treatment facility for the treatment of heroin, 
cocaine, methamphetamine, 3,4-methylenedioxy-
methamphetamine, or phencyclidine abuse or 
addiction; or 
‘‘(ii) received treatment for heroin, cocaine, 
methamphetamine, 3,4-methylenedioxymetham-
phetamine, or phencyclidine abuse or addiction 
from an intensive outpatient treatment facility; 
and 
‘‘(B) after successful completion of such 
treatment reenters the community. 
‘‘(2) INTENSIVE OUTPATIENT TREATMENT FA-
CILITY.—The term ‘intensive outpatient treatment 
facility’ means a facility that provides treatment for 
VerDate Mar 15 2010 
22:54 May 14, 2012
Jkt 019200
PO 00000
Frm 00010
Fmt 6652
Sfmt 6201
E:\BILLS\H5711.IH
H5711
srobinson on DSK4SPTVN1PROD with BILLS
substance abuse and that, with respect to an indi-
vidual receiving such treatment— 
‘‘(A) provides a minimum of seven hours of 
treatment for substance abuse during a week; 
‘‘(B) provides regularly scheduled treat-
ment sessions within a structured program; and 
‘‘(C) ensures that the treatment sessions 
are led by health professionals or clinicians. 
‘‘(3) RESIDENTIAL INPATIENT TREATMENT FA-
CILITY.—The term ‘residential inpatient treatment 
facility’ means a facility that provides treatment for 
substance abuse in which health professionals and 
clinicians provide a planned regimen of 24-hour pro-
fessionally directed evaluation, care, and treatment 
for such substance abuse in an inpatient setting, in-
cluding 24-hour observation and monitoring. 
‘‘(4) 
WRAP-AROUND
SERVICES.—The 
term 
‘wrap-around services’ means, with respect to a her-
oin, cocaine, methamphetamine, 3,4-methylenedioxy-
methamphetamine, or phencyclidine-affected indi-
vidual, the following services: 
‘‘(A) Medical services. 
‘‘(B) Dental services. 
‘‘(C) Mental health services. 
‘‘(D) Child care services. 
VerDate Mar 15 2010 
22:54 May 14, 2012
Jkt 019200
PO 00000
Frm 00011
Fmt 6652
Sfmt 6201
E:\BILLS\H5711.IH
H5711
srobinson on DSK4SPTVN1PROD with BILLS